Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - pegvisomant, quantity: 10 mg - injection, solution - excipient ingredients: water for injections - the treatment of acromegaly in patients who have had inadequate response to surgery and/or radiation and/or other medical therapies or for whom these therapies are not appropriate. the treatment goal is to normalise igf-1 levels.

European Union - English - EMA (European Medicines Agency)

pfizer europe ma eeig - pegvisomant - acromegaly - pituitary and hypothalamic hormones and analogues - treatment of adult patients with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalize igf-i concentrations or was not tolerated.treatment of adult patients with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalize igf -i concentrations or was not tolerated.

Canada - English - Health Canada

pfizer canada ulc - pegvisomant - kit - 10mg - pegvisomant 10mg - somatotropin antagonists

Canada - English - Health Canada

pfizer canada ulc - pegvisomant - kit - 15mg - pegvisomant 15mg - somatotropin antagonists

Canada - English - Health Canada

pfizer canada ulc - pegvisomant - kit - 20mg - pegvisomant 20mg - somatotropin antagonists

Canada - English - Health Canada

pfizer canada ulc - pegvisomant - kit - 25mg - pegvisomant 25mg - somatotropin antagonists

Canada - English - Health Canada

pfizer canada ulc - pegvisomant - kit - 30mg - pegvisomant 30mg - somatotropin antagonists

Israel - English - Ministry of Health

pfizer pharmaceuticals israel ltd - pegvisomant - powder and solvent for solution for injection - pegvisomant 25 mg/vial - pegvisomant - treatment of adult patients with acromegaly who have had an inadequate response to surgery and/or radiation therapy, and in whom an appropriate medical treatment with somatostatin analogues did not normalize igf-i concentrations or was not tolerated.

Israel - English - Ministry of Health

pfizer pharmaceuticals israel ltd - pegvisomant - powder and solvent for solution for injection - pegvisomant 30 mg/vial - pegvisomant - treatment of adult patients with acromegaly who have had an inadequate response to surgery and/or radiation therapy, and in whom an appropriate medical treatment with somatostatin analogues did not normalize igf-i concentrations or was not tolerated.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - pegvisomant - powder and solvent for solution for injection - 10mg